By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – New England Biolabs and Sequenom said after the close of the market on Tuesday they have signed a licensing and co-marketing agreement for the commercialization of tools for epigenetics research.

They also announced the launch of the first product stemming from the research collaboration, which served as the basis for the agreement, the EpiMark Methylated DNA Enrichment Kit from NEB.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.